Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Florida OIR Orders Unlicensed RRG to Cease and Desist After Owners Arrested 
McKinsey Rebukes Partner Who Questioned Challenges Facing Women CEOs 
Florida Commissioner Suspends A-Cap’s Atlantic Coast Life Over Surplus Issues 
New Jersey Employers Should Prepare Now for Oct. 1 Independent Contractor Rule 
